CSL Limited (ASX:CSL) faces a Victorian shareholder class action over FY26 disclosure, creating a fresh overhang on the ...

At Stocks Down Under, we're as concerned about the lack of ASX IPOs as private equity is. But this author's jaw dropped upon ...

Fortescue (ASX:FMG) shipped 46.8Mt in Q1 FY27 but sold only 42.9Mt as the CMRG pricing dispute leaves inventory piling up.

The British business just grew sales 29%. Nick Scali (ASX:NCK) has told the market to expect underlying net profit after tax ...

Santos (ASX:STO) posted record 26.3 mmboe production and US$1.07bn free cash flow as Barossa and Pikka finally delivered.

Visit the website of BridgeBio Pharma (NDQ:BBIO), and you'll find it describes itself as 'a unique biotechnology company advancing genetic medicines via a ...

Ascendis Pharma (NDQ:ASND) has a portfolio of drugs that could be the most important to hit the market since BioMarin's Voxzogo (vosoritide). This became one ...

Wisr (ASX:WZR) upgrades FY27 Cash NPAT guidance 40% to at least A$7m as loan originations hit a record A$253.8m and the book ...

LinQ Minerals (ASX:LNQ) reports 429m of visual mineralisation at Gidginbung South, with assays due in 6 to 8 weeks to confirm ...

SpaceX (NSDQ:SPCX) delivered US$14.6bn Q3 revenue as Super Intelligence turned profitable, but investors still face a ...

Roivant Sciences (NASDAQ:ROIV) has spent the past decade attempting something uncommon in the biotech space. Namely, creating a system for repeatedly building ...

NEXTDC (ASX:NXT) has cut FY27 revenue and EBITDA guidance by around A$140m after Jemena suspended power works at its M3 ...